Product details Net content: 10 mg per vial Format: Lyophilized material Container: 3 mL glass vial Lot/batch: Recorded on product label where available Intended use Non-clinical laboratory research Analytical reference and assay development within institutional programs Use only in accordance with institutional SOPs and applicable regulatory requirements Not for human or animal consumption Not for clinical, therapeutic, diagnostic, cosmetic, or personal use Certificate of Analysis (COA) For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for BPC-157 Canada 10mg
This bacteriostatic rather than bactericidal preservative action maintains solution sterility between multiple vial access events and the defining practical advantage of Bacteriostatic Water over unpreserved Sterile Water for Injection, which must be used immediately upon vial entry or discarded to prevent microbial contamination
Available as subcutaneous injection, sublingual spray, or oral capsule
The same biology applies to a surgical site
Two randomized controlled trials, three prospective papers, one systematic review, and three clinical reviews fulfilled inclusion criteria
In a 2017 study published in the Journal of Molecular Medicine , Hsieh and colleagues reported that BPC-157 promoted angiogenesis in chick chorioallantoic membrane and endothelial tube-formation assays and accelerated blood-flow recovery in a rat hindlimb ischemia model, with the effect attributed to activation of the VEGFR2-Akt-eNOS signaling pathway [1]
